$12.60
0.68[5.70%]
At close: May 23
$12.60
0[0.00%]
After Hours: 9:16AM EDT
Cidara Therapeutics: Insider buying and selling updated today.
Mar 12, 2024 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -21.029K | $0.67 | -$14.09K | SELL | -7.48% | 260.165K | Mar 11 | View |
Mar 12, 2024 | Taylor Sandison | CHIEF MEDICAL OFFICER | -20.662K | $0.67 | -$13.84K | SELL | -5.62% | 347.095K | Mar 11 | View |
Mar 12, 2024 | Shane Ward | COO & CLO | -20.473K | $0.67 | -$13.71K | SELL | -9.34% | 198.77K | Mar 11 | View |
Mar 12, 2024 | Preetam Shah | CFO & CBO | -18.931K | $0.67 | -$12.68K | SELL | -7.69% | 227.21K | Mar 11 | View |
Sep 13, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -18.469K | $0.95 | -$17.51K | SELL | -6.25% | 277.194K | Sep 11 | View |
Sep 13, 2023 | Taylor Sandison | CHIEF MEDICAL OFFICER | -18.793K | $0.95 | -$17.81K | SELL | -4.91% | 363.757K | Sep 11 | View |
Aug 14, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 10K | $0.97 | $9.70K | BUY | 3.50% | 295.663K | Aug 14 | View |
Aug 08, 2023 | Jeffrey Stein | PRESIDENT & CEO | 50K | $0.96 | $47.88K | BUY | 15.45% | 373.611K | Aug 08 | View |
Mar 27, 2023 | Jeffrey Stein | PRESIDENT & CEO | 50K | $1.04 | $51.85K | BUY | 18.27% | 323.611K | Mar 27 | View |
Mar 13, 2023 | Shane Ward | COO & CLO | -4.329K | $1.53 | -$6.62K | SELL | -4.87% | 84.576K | Mar 13 | View |
Mar 13, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -7.562K | $1.53 | -$11.57K | SELL | -3.80% | 191.663K | Mar 13 | View |
Mar 13, 2023 | Preetam Shah | CFO & CBO | -6.648K | $1.53 | -$10.17K | SELL | -4.29% | 148.141K | Mar 13 | View |
Mar 13, 2023 | Taylor Sandison | CHIEF MEDICAL OFFICER | -7.203K | $1.53 | -$11.02K | SELL | -2.44% | 288.55K | Mar 13 | View |
Jan 27, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -11.814K | $1.20 | -$14.18K | SELL | -5.60% | 199.225K | Jan 12 | View |
Sep 19, 2022 | Preetam Shah | CFO & CBO | 34.358K | $0.77 | -$12.03K | SELL-OPTIONS | 29.51% | 150.789K | Sep 15 - Sep 19 | View |
Sep 13, 2022 | Taylor Sandison | CHIEF MEDICAL OFFICER | -18.478K | $0.68 | -$12.66K | SELL | -5.96% | 291.753K | Sep 12 | View |
Sep 13, 2022 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -18.159K | $0.68 | -$12.44K | SELL | -8.06% | 207.039K | Sep 12 | View |
Sep 13, 2022 | Paul Daruwala | CHIEF OPERATING OFFICER | -16.199K | $0.68 | -$11.09K | SELL | -6.83% | 221.099K | Sep 12 | View |
Mar 23, 2022 | Brady Johnson | VICE PRESIDENT, FINANCE | -654 | $0.81 | -$529.74 | SELL | -1.31% | 49.366K | Mar 21 | View |
Mar 11, 2022 | Brady Johnson | VICE PRESIDENT, FINANCE | -945 | $0.71 | -$670.95 | SELL | -1.85% | 50.02K | Mar 11 | View |
Jan 07, 2022 | Paul Daruwala | CHIEF OPERATING OFFICER | 4.767K | $1.25 | -$6.42K | SELL-OPTIONS | 2.61% | 187.298K | Dec 29 - Jan 05 | View |
Jan 07, 2022 | Brady Johnson | VICE PRESIDENT, FINANCE | -154 | $1.25 | -$520.00 | SELL | -0.30% | 50.965K | Dec 29 - Jan 05 | View |
Jan 07, 2022 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 849 | $1.25 | -$1.56K | SELL-OPTIONS | 0.51% | 168.698K | Dec 29 - Jan 05 | View |
Nov 15, 2021 | Jeffrey Stein | PRESIDENT & CEO | 50K | $1.59 | $79.53K | BUY | 10.92% | 507.887K | Nov 12 | View |
Nov 15, 2021 | Preetam Shah | CFO & CBO | 20K | $1.54 | $30.80K | BUY | ∞ | 20K | Nov 12 | View |
Sep 14, 2021 | Timothy R Franson | DIRECTOR | 7K | $2.12 | $14.82K | BUY | 175.00% | 11K | Sep 13 | View |
Aug 19, 2021 | Jeffrey Stein | PRESIDENT & CEO | 50K | $1.74 | $86.75K | BUY | 12.26% | 457.887K | Aug 18 - Aug 19 | View |
Apr 05, 2021 | Neil Abdollahian | CHIEF BUSINESS OFFICER | -837 | $2.26 | -$9.82K | SELL | -1.44% | 57.471K | Jan 05 - Apr 01 | View |
Apr 05, 2021 | Paul Daruwala | CHIEF OPERATING OFFICER | -2.061K | $2.16 | -$7.49K | SELL | -3.92% | 50.531K | Jan 05 - Apr 01 | View |
Apr 05, 2021 | Jessica Oien | GENERAL COUNSEL & SECRETARY | 799 | $2.41 | -$4.83K | GRANT | 11.47% | 7.764K | Jan 05 - Apr 01 | View |
Browse insider trades on all stocks.